NIH R21 grants for research on Alzheimer’s and related dementias (clinical trial optional)
The National Institute on Aging invites R21 applications for exploratory, interdisciplinary research on Alzheimer’s disease and related dementias; clinical trials are optional. Projects should address current high-priority topics to advance understanding of disease heterogeneity, causes, prevention, and treatment. Additional topic guidance will be issued in subsequent Notices.
Alzheimer’s disease (AD) is a progressive, degenerative disorder of the brain and is the most common form of dementia of the aging. AD is the seventh leading cause of death in the United States. Prominent behavioral manifestations of AD include memory impairments and decline in other cognitive d…
Funding Source
Awards & funding
Eligibility
- Foreign/Non-domestic eligibility: Non-domestic (non-U.S.) entities (foreign organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are eligible to apply. Foreign components (as defined in the NIH Grants Policy Statement) are allowed.
- Require…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers